Osaic Holdings’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $140K | Buy |
10,083
+3,476
| +53% | +$48.4K | ﹤0.01% | 3899 |
|
2025
Q1 | $103K | Sell |
6,607
-3,568
| -35% | -$55.8K | ﹤0.01% | 4131 |
|
2024
Q4 | $142K | Buy |
10,175
+7,747
| +319% | +$108K | ﹤0.01% | 3896 |
|
2024
Q3 | $22.6K | Buy |
2,428
+138
| +6% | +$1.28K | ﹤0.01% | 5267 |
|
2024
Q2 | $21.3K | Sell |
2,290
-26,336
| -92% | -$245K | ﹤0.01% | 5259 |
|
2024
Q1 | $284K | Buy |
28,626
+7,358
| +35% | +$72.9K | ﹤0.01% | 3385 |
|
2023
Q4 | $68.7K | Buy |
21,268
+19,142
| +900% | +$61.8K | ﹤0.01% | 4682 |
|
2023
Q3 | $11.3K | Buy |
2,126
+1,084
| +104% | +$5.76K | ﹤0.01% | 5821 |
|
2023
Q2 | $9.96K | Buy |
1,042
+400
| +62% | +$3.83K | ﹤0.01% | 5928 |
|
2023
Q1 | $7.2K | Buy |
642
+100
| +18% | +$1.12K | ﹤0.01% | 6113 |
|
2022
Q4 | $8K | Buy |
542
+85
| +19% | +$1.26K | ﹤0.01% | 6026 |
|
2022
Q3 | $9K | Hold |
457
| – | – | ﹤0.01% | 6023 |
|
2022
Q2 | $11K | Buy |
457
+57
| +14% | +$1.37K | ﹤0.01% | 5981 |
|
2022
Q1 | $8K | Hold |
400
| – | – | ﹤0.01% | 6210 |
|
2021
Q4 | $8K | Sell |
400
-330
| -45% | -$6.6K | ﹤0.01% | 6318 |
|
2021
Q3 | $18K | Sell |
730
-2,034
| -74% | -$50.2K | ﹤0.01% | 5824 |
|
2021
Q2 | $75K | Buy |
2,764
+2,058
| +292% | +$55.8K | ﹤0.01% | 4720 |
|
2021
Q1 | $21K | Sell |
706
-11,255
| -94% | -$335K | ﹤0.01% | 5401 |
|
2020
Q4 | $336K | Buy |
11,961
+11,561
| +2,890% | +$325K | ﹤0.01% | 3015 |
|
2020
Q3 | $12K | Hold |
400
| – | – | ﹤0.01% | 5144 |
|
2020
Q2 | $12K | Hold |
400
| – | – | ﹤0.01% | 5045 |
|
2020
Q1 | $12K | Buy |
+400
| New | +$12K | ﹤0.01% | 4849 |
|